198 related articles for article (PubMed ID: 34499915)
1. Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells.
Bernhauerová V; Lisowski B; Rezelj VV; Vignuzzi M
J Theor Biol; 2021 Dec; 531():110895. PubMed ID: 34499915
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
3. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
[TBL] [Abstract][Full Text] [Related]
4. Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing.
Zecha J; Lee CY; Bayer FP; Meng C; Grass V; Zerweck J; Schnatbaum K; Michler T; Pichlmair A; Ludwig C; Kuster B
Mol Cell Proteomics; 2020 Sep; 19(9):1503-1522. PubMed ID: 32591346
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Coronavirus Entry
Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
[TBL] [Abstract][Full Text] [Related]
6. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
7. 17β-estradiol reduces SARS-CoV-2 infection in vitro.
Lemes RMR; Costa AJ; Bartolomeo CS; Bassani TB; Nishino MS; Pereira GJDS; Smaili SS; Maciel RMB; Braconi CT; da Cruz EF; Ramirez AL; Maricatto JT; Janini LMR; Prado CM; Stilhano RS; Ureshino RP
Physiol Rep; 2021 Jan; 9(2):e14707. PubMed ID: 33463909
[TBL] [Abstract][Full Text] [Related]
8. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
[TBL] [Abstract][Full Text] [Related]
9. UV-4B potently inhibits replication of multiple SARS-CoV-2 strains in clinically relevant human cell lines.
Franco EJ; Warfield KL; Brown AN
Front Biosci (Landmark Ed); 2022 Jan; 27(1):3. PubMed ID: 35090308
[TBL] [Abstract][Full Text] [Related]
10. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
[TBL] [Abstract][Full Text] [Related]
11. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells.
Barreto-Vieira DF; da Silva MAN; Garcia CC; Miranda MD; Matos ADR; Caetano BC; Resende PC; Motta FC; Siqueira MM; Girard-Dias W; Archanjo BS; Barth OM
Mem Inst Oswaldo Cruz; 2021; 116():e200443. PubMed ID: 33566951
[TBL] [Abstract][Full Text] [Related]
12. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.
Mautner L; Hoyos M; Dangel A; Berger C; Ehrhardt A; Baiker A
Virol J; 2022 Apr; 19(1):76. PubMed ID: 35473640
[TBL] [Abstract][Full Text] [Related]
13. Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions.
Omer D; Pleniceanu O; Gnatek Y; Namestnikov M; Cohen-Zontag O; Goldberg S; Friedman YE; Friedman N; Mandelboim M; Vitner EB; Achdout H; Avraham R; Zahavy E; Israely T; Mayan H; Dekel B
J Am Soc Nephrol; 2021 Sep; 32(9):2242-2254. PubMed ID: 34112705
[TBL] [Abstract][Full Text] [Related]
14. Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineering.
Sohail A; Nutini A
Prog Biophys Mol Biol; 2020 Sep; 155():29-35. PubMed ID: 32360608
[TBL] [Abstract][Full Text] [Related]
15. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.
Ge XY; Li JL; Yang XL; Chmura AA; Zhu G; Epstein JH; Mazet JK; Hu B; Zhang W; Peng C; Zhang YJ; Luo CM; Tan B; Wang N; Zhu Y; Crameri G; Zhang SY; Wang LF; Daszak P; Shi ZL
Nature; 2013 Nov; 503(7477):535-8. PubMed ID: 24172901
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
[TBL] [Abstract][Full Text] [Related]
18. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
20. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
Ramirez S; Fernandez-Antunez C; Galli A; Underwood A; Pham LV; Ryberg LA; Feng S; Pedersen MS; Mikkelsen LS; Belouzard S; Dubuisson J; Sølund C; Weis N; Gottwein JM; Fahnøe U; Bukh J
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0009721. PubMed ID: 33903110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
